Optimal management of chronic gout: attempting to render the (t)issues crystal-clear.
Min Loke
ML
Wong
D000493:Allopurinol / Q000009:adverse effects / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects; D001553:Benzbromarone / Q000627:therapeutic use; D002908:Chronic Disease; D003078:Colchicine / Q000008:administration & dosage / Q000009:adverse effects; D004342:Drug Hypersensitivity / Q000209:etiology; D006073:Gout / Q000097:blood / Q000188:drug therapy* / Q000652:urine; D006801:Humans; D014527:Uric Acid / Q000097:blood / Q000652:urine; D014528:Uricosuric Agents / Q000008:administration & dosage* / Q000009:adverse effects
D000893:Anti-Inflammatory Agents; D014528:Uricosuric Agents; D014527:Uric Acid; D001553:Benzbromarone; D000493:Allopurinol; D003078:Colchicine